...
首页> 外文期刊>Combinatorial chemistry & high throughput screening >Silico discovery and virtual screening of multi-target inhibitors for proteins in mycobacterium tuberculosis
【24h】

Silico discovery and virtual screening of multi-target inhibitors for proteins in mycobacterium tuberculosis

机译:结核分枝杆菌中蛋白质的多靶点抑制剂的计算机模拟发现和虚拟筛选

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mycobacterium tuberculosis (MTB) is the principal pathogen which causes tuberculosis (TB), a disease that remains as one of the most alarming health problems worldwide. An active area for the search of new anti-TB therapies is concerned with the use of computational approaches based on Chemoinformatics and/or Bioinformatics toward the discovery of new and potent anti-TB agents. These approaches consider only small series of structurally related compounds and the studies are generally realized for only one target like a protein. This fact constitutes an important limitation. The present work is an effort to overcome this problem. We introduce here the first chemo-bioinformatic approach by developing a multi-target (mt) QSAR discriminant model, for the in silico design and virtual screening of anti-TB agents against six proteins in MTB. The mt-QSAR model was developed by employing a large and heterogeneous database of compounds and substructural descriptors. The model correctly classified more than 90% of active and inactive compounds in both, training and prediction series. Some fragments were extracted from the molecules and their contributions to anti-TB activity through inhibition of the six proteins, were calculated. Several fragments were identified as responsible for anti-TB activity and new molecular entities were designed from those fragments with positive contributions, being suggested as possible anti-TB agents.
机译:结核分枝杆菌(MTB)是导致结核病(TB)的主要病原体,该病一直是全世界最令人担忧的健康问题之一。寻找新的抗结核疗法的活跃领域涉及使用基于化学信息学和/或生物信息学的计算方法来发现新的和有效的抗结核病药物。这些方法仅考虑少量结构相关的化合物,并且通常仅针对一个目标(如蛋白质)实现研究。这一事实构成了重要的限制。当前的工作是克服这个问题的努力。我们在这里通过开发多目标(mt)QSAR判别模型介绍了第一种化学生物信息学方法,用于计算机设计和针对MTB中六种蛋白质的抗结核病药物的虚拟筛选。 mt-QSAR模型是通过使用大型且异构的化合物和亚结构描述符数据库开发的。该模型正确地将训练和预测系列中超过90%的活性和非活性化合物分类。从分子中提取了一些片段,并计算了它们通过抑制六种蛋白质对抗结核活性的贡献。已鉴定出几个片段负责抗结核活性,并从这些片段中设计了具有积极作用的新分子实体,被认为是可能的抗结核药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号